Revolutionizing cancer immunotherapy: The dual role of clofazimine in enhancing efficacy and reducing toxicity

Yiran Zhu; Yong Lu

doi:10.1002/ctm2.1756

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (7) : e1756 DOI: 10.1002/ctm2.1756

COMMENTARY

Revolutionizing cancer immunotherapy: The dual role of clofazimine in enhancing efficacy and reducing toxicity

Yiran Zhu
, Yong Lu ^†

Author information +

History +

PDF

Keywords

cancer immunotherapy / clofazimine / immune-related adverse events / immune checkpoint blockade

Cite this article

Download citation ▾

Yiran Zhu, Yong Lu. Revolutionizing cancer immunotherapy: The dual role of clofazimine in enhancing efficacy and reducing toxicity. Clinical and Translational Medicine, 2024, 14(7): e1756 DOI:10.1002/ctm2.1756

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.